A detailed history of Waldron Private Wealth LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Waldron Private Wealth LLC holds 4,690 shares of AZN stock, worth $329,472. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,690
Previous 3,838 22.2%
Holding current value
$329,472
Previous $299,000 2.68%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$63.2 - $79.58 $53,846 - $67,802
852 Added 22.2%
4,690 $307,000
Q3 2024

Oct 21, 2024

BUY
$76.67 - $87.62 $24,074 - $27,512
314 Added 8.91%
3,838 $299,000
Q2 2024

Jul 31, 2024

BUY
$66.81 - $80.83 $235,438 - $284,844
3,524 New
3,524 $274,000
Q4 2023

Aug 29, 2024

SELL
$61.89 - $69.28 $20,114 - $22,516
-325 Reduced 9.22%
3,199 $215,000
Q4 2023

Jan 30, 2024

BUY
$61.89 - $69.28 $197,986 - $221,626
3,199 New
3,199 $215,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $218B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Waldron Private Wealth LLC Portfolio

Follow Waldron Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.